Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
about
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Intrinsic and acquired resistance mechanisms in enterococcus.Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin.Luteolin potentiates the effects of aminoglycoside and β-lactam antibiotics against methicillin-resistant Staphylococcus aureus in vitro.Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinationsThe Interplay between Daptomycin and the Immune System.The effectiveness of negative pressure therapy on infected wounds: preliminary results.Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.Synergistic effect of emodin in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus.Daptomycin.Antibacterial mode of action of violacein from Chromobacterium violaceum UTM5 against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA).
P2860
Q34478074-CE447F52-E348-4075-AB02-2BDEEE13DA4FQ36362547-EDD045A9-A1CE-425F-B638-F714D9E03D68Q36401160-A0037155-B264-418E-B1D5-5136EB3F4F1CQ36953336-1FF8D767-55BA-4957-8356-5017F4B200BEQ37144883-326F43AA-2F95-4A1B-A119-3AD9115E13A7Q38191612-045D8F28-A197-4F6D-973C-B423CE265027Q38960970-0EB17424-F64A-4625-9F99-E99CD4AB2083Q40362524-90E1AF34-062D-45FD-8C01-DCCFC33959A7Q41817273-7BFF9BB4-98BF-4207-98DB-5DD3D56D6B75Q42868516-3A88B993-09D1-4CF8-8D74-957ED8CD8944Q47616115-FE858409-4565-440A-9A20-B9753652D80FQ51080120-A6F788B4-4FDE-4738-BBF4-5AF27BDAFCB7
P2860
Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Antimicrobial activities of da ...... against Staphylococcus aureus.
@en
Antimicrobial activities of da ...... against Staphylococcus aureus.
@nl
type
label
Antimicrobial activities of da ...... against Staphylococcus aureus.
@en
Antimicrobial activities of da ...... against Staphylococcus aureus.
@nl
prefLabel
Antimicrobial activities of da ...... against Staphylococcus aureus.
@en
Antimicrobial activities of da ...... against Staphylococcus aureus.
@nl
P2093
P2860
P356
P1476
Antimicrobial activities of da ...... against Staphylococcus aureus.
@en
P2093
Aldona L Baltch
Lawrence H Bopp
Phyllis B Michelsen
Raymond P Smith
William J Ritz
P2860
P304
P356
10.1128/AAC.00973-06
P407
P577
2007-02-05T00:00:00Z